Shire gets EU approval for Reminyl

Shire (LSE:SHP; SHPGY) received marketing approval from Sweden for Reminyl galantamine to treat dementia of the Alzheimer's type. Reminyl will be submitted to the EU Mutual Recognition Procedure to ga...